Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults

NCT03342898 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
900
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda